Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea

J Antimicrob Chemother. 2004 Jun;53(6):1095-7. doi: 10.1093/jac/dkh219. Epub 2004 Apr 29.

Abstract

Objectives: Our aim was to study the antimicrobial susceptibilities and macrolide resistance mechanisms of viridans group streptococci (VGS) in a Korean tertiary hospital.

Methods: MICs of five antimicrobials were determined for 106 VGS isolated from blood cultures. The macrolide resistance mechanisms of erythromycin non-susceptible isolates were studied by the double-disc test and PCR.

Results: In all, 42.4% of the isolates were susceptible to penicillin. Nine of 61 penicillin non-susceptible isolates were fully resistant (MIC >/= 4 mg/L). Rates of non-susceptibility to erythromycin, clindamycin and ceftriaxone were 33.9%, 17.9% and 9.4%, respectively. Twenty-two (61.1%) of 36 erythromycin non-susceptible isolates expressed constitutive resistance to macrolide-lincosamide-streptogramin B antibiotics (a constitutive MLS(B) phenotype); 13 isolates (36.1%) expressed an M phenotype; and one isolate, a Streptococcus bovis isolate, had an inducible MLS(B) resistance phenotype. erm(B) was found in isolates with constitutive/inducible MLS(B) phenotypes, and mef(A) in isolates with the M phenotype. In three isolates (two isolates with a constitutive MLS(B) phenotype and in one isolate with the M phenotype), none of erm(A), erm(B), erm(C) or mef(A) was detected by PCR.

Conclusions: Penicillin non-susceptible VGS were more resistant to erythromycin, clindamycin and ceftriaxone than were penicillin-susceptible isolates. A constitutive MLS(B) phenotype associated with erm(B) was the predominant mechanism of macrolide resistance among erythromycin non-susceptible isolates from this Korean hospital.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Cross Infection / microbiology
  • Drug Resistance, Bacterial
  • Erythromycin / pharmacology
  • Genes, Bacterial / genetics
  • Genotype
  • Humans
  • Korea
  • Macrolides / pharmacology*
  • Phenotype
  • Reverse Transcriptase Polymerase Chain Reaction
  • Streptococcal Infections / blood
  • Streptococcal Infections / microbiology*
  • Viridans Streptococci / drug effects*
  • Viridans Streptococci / genetics*

Substances

  • Anti-Bacterial Agents
  • Macrolides
  • Erythromycin